Molecular Data Inc. (Nasdaq: MKD) has filed its annual report on Form 20-F for the fiscal year ended December 31, 2019, with the U.S. Securities and Exchange Commission on June 12, 2020. The annual report is accessible on the Company's investor relations website, with hard copies available upon request for shareholders and ADS holders. Molecular Data operates as a technology-driven platform in China's chemical industry, offering e-commerce solutions, financial solutions, warehousing, logistics, and a SaaS suite to connect participants in the chemical value chain.
Molecular Data Inc. (Nasdaq: MKD) has appointed Mr. Yanbin Wang as an independent director on its board, effective May 20, 2020. Mr. Wang, currently a senior vice president at Borouge Pte. Ltd., brings significant experience from his tenure in the financial and chemical industries, including KPMG and AkzoNobel. His appointment expands the board to five members, enhancing governance and strategic oversight. This addition aims to leverage Mr. Wang's extensive industry background to support the company's growth in China's chemical sector.
Molecular Data Inc. (NASDAQ: MKD) has established a strategy advisory committee, appointing Junling Li, former Alibaba Group VP, as its president. This decision comes as the company embarks on a new strategic phase post-IPO in December 2019, especially in response to challenges posed by COVID-19. Dr. Zheng Wang, CEO, emphasized leveraging technological advancements in big data and AI to improve operational efficiency within the chemical industry. The platform provides various integrated solutions aimed at connecting participants in the chemical value chain.